Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03616990 · ClinicalTrials.gov registry record · NA

Supportive Release Center Study

A NA study of Substance Use and Mental Health, sponsored by University of Chicago.

Active
Registry status
NA
Development phase
15,195
Enrollment target
1
Study location

NCT03616990: Active NA study of Substance Use and Mental Health, sponsored by University of Chicago.

NCT03616990 is a NA study of Substance Use and Mental Health that is active but no longer recruiting, run by University of Chicago. The registered enrollment target is 15,195 participants, above the 1,088-participant average among 88 other Substance Use trials with a reported enrollment target (1297% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03616990, a NA study of Substance Use and Mental Health, is active but no longer recruiting, sponsored by University of Chicago.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
15,195 participants
Enrollment target
1
Study location

Study Summary

The Supportive Release Center (SRC) is a collaboration between the University of Chicago Urban Health Lab, Treatment Alternatives for Safe Communities, Heartland Alliance Health, and the Cook County Sheriff's office. The aim of the SRC is to identify individuals with mental illnesses, substance use disorders, and other vulnerabilities as they are released from the Cook County Jail (CCJ), provide an improved environment to assess needs of these individuals, and facilitate effective linkages with social services following release, including medical care and substance use or mental health treatment. The SRC improves the current standard of care offered at the CCJ by introducing mechanisms to facilitate engagement with post-release services and address individuals' immediate acute needs. The primary objective of this randomized controlled trial is to evaluate the impact of assignment to the SRC on the number of arrests within one year of study enrollment among eligible men being released from the Cook County Jail. Researchers hypothesize that the SRC is more effective than usual care at facilitating and ensuring receipt of transition services and care, and that receipt of this treatment will decrease the number of arrests within one year of study enrollment.

Primary Outcome

Number of re-arrests within 365 days of study enrollment, measured at the individual level using Illinois State Police arrest records. Follow-up will begin the day an individual is first randomized (index randomization) and ITT group membership will be based upon index treatment assignment. Given expected dispersion and excess zeroes in the final dataset, the ITT treatment effect will be modeled using zero-inflated negative binomial regression. ITT analyses will be supplemented by a TOT analysis

Interventions

  • BEHAVIORAL TASC Service Linkages - Discharge Area Only
  • BEHAVIORAL SRC Overnight Stay
  • BEHAVIORAL TASC Services Linkages - SRC Onsite
  • BEHAVIORAL APN Appointment

Study Locations (1)

Illinois

  • Cook County Department of Corrections & SRC - Chicago

Trial Details

FieldValue
Enrollment Target 15,195 participants
Start Date 2017-11-06
Est. Completion 2025-12-31
Phase NA
University of Chicago

796 total trials

What the registry record for NCT03616990 still lists

NCT03616990 is an interventional study that assigns participants to a tested intervention. Its 15,195 participants enrollment target places it among the larger protocols in the corpus, above the 1,088-participant average among 88 other Substance Use trials with a reported enrollment target (1297% higher).

The record links to 5 conditions, with Substance Use appearing as the primary indexed condition, and to 4 interventions - of which TASC Service Linkages - Discharge Area Only is the first listed.

NCT03616990 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT03616990 about?

NCT03616990 is a clinical study titled "Supportive Release Center Study". The Supportive Release Center (SRC) is a collaboration between the University of Chicago Urban Health Lab, Treatment Alternatives for Safe Communities, Heartland Alliance Health, and the Cook County Sheriff's office. The aim of the SRC is to identify individuals with mental illnesses, substance use ...

What is the current status of trial NCT03616990?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 15,195 participants. The study started on 2017-11-06. Estimated completion is 2025-12-31.

What conditions does trial NCT03616990 study?

This clinical trial studies the following conditions: Substance Use, Mental Health, Mental Health Services, Recidivism, Continuity of Patient Care.

What interventions are being tested in trial NCT03616990?

The interventions under investigation include: TASC Service Linkages - Discharge Area Only (BEHAVIORAL), SRC Overnight Stay (BEHAVIORAL), TASC Services Linkages - SRC Onsite (BEHAVIORAL), APN Appointment (BEHAVIORAL).

Who is sponsoring clinical trial NCT03616990?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03616990 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03616990's enrollment target sits among peer trials

15,195 2nd of 88 the highest of 88 other Substance Use trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Substance Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07000357 · 15,100 participants · Phase 3

    A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

  • NCT00857922 · 15,000 participants

    Neurosciences Research Repository

  • NCT01137643 · 15,000 participants

    Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

  • NCT01550575 · 15,000 participants

    Patient Retrospective Outcomes (PRO)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03616990, the US trial registry maintained by the National Library of Medicine. NCT03616990 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.